Yuxiang Qiu

696 citations
17 papers · 482 indexed · 1 hit paper · h-index 11
Topics
Cancer-related molecular mechanisms research (4 papers)RNA Research and Splicing (4 papers)RNA modifications and cancer (3 papers)

In The Last Decade

Yuxiang Qiu

15 papers receiving 478 citations

Hit Papers

Glucose‐Responsive and Analgesic Gel for Diabetic Subcuta...202520262025510152025

Peers

Yuxiang Qiu
Comparison fields: 5 of 73
  • Molecular Biology 344
  • Cancer Research 247
  • Oncology 82
  • Immunology 54
  • Pulmonary and Respiratory Medicine 38
Replace Zumin Xu with:
Zumin Xu China
Rossella Loria Italy
Riccardo Cazzoli Italy
Huixia Huang China
Liang Deng China
Isabelle Moranvillier France
Alexander Ou United States
Yuxiang Qiu relative to Zumin Xu China Zumin Xu's profile →
Citations per field
00.5×7.7×
Zumin Xu · 1×
Citations per year

Countries citing papers authored by Yuxiang Qiu

Since Specialization
Citations

This map shows the geographic impact of Yuxiang Qiu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yuxiang Qiu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yuxiang Qiu more than expected).

Fields of papers citing papers by Yuxiang Qiu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yuxiang Qiu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yuxiang Qiu. The network helps show where Yuxiang Qiu may publish in the future.

Co-authorship network of co-authors of Yuxiang Qiu

This figure shows the co-authorship network connecting the top 25 collaborators of Yuxiang Qiu. A scholar is included among the top collaborators of Yuxiang Qiu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yuxiang Qiu. Yuxiang Qiu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
#WorkIndexed citations
1 4
2 13
3 1
4 0
5
Glucose‐Responsive and Analgesic Gel for Diabetic Subcutaneous Abscess Treatment by Simultaneously Boosting Photodynamic Therapy and Relieving Hypoxiabreakdown →
25
6 29
7 0
8 8
9 23
10 22
11 8
12 85
13 171
14 25
15 14
16 29
17 25

About Yuxiang Qiu

Yuxiang Qiu is a scholar working on Cancer Research, Molecular Biology and Immunology and Allergy, having authored 17 papers that have together received 482 indexed citations. Recurring topics across this work include Cancer-related molecular mechanisms research (4 papers), RNA Research and Splicing (4 papers) and RNA modifications and cancer (3 papers). The work is most often cited by research in Cancer Research (247 citations), Molecular Biology (344 citations) and Oncology (82 citations). Yuxiang Qiu has collaborated with scholars based in China, United States and Belarus. Frequent co-authors include Manran Liu, Xueying Wan, Yilu Qin, Huan Zeng, Yixuan Hou, Ting Jin, Yina Qiao, Peng‐Peng Zhu, Liping Yang and Gang Tu. Their work appears in journals such as Nature Communications, Cancer Research and Oncogene.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026